SPC224
Selexipag
Status:
VeittApplication date:
3.5.2018Application published:
15.6.2018Grant published:
15.6.2020
Max expiry date:
18.5.2031Medicine name:
UptraviMedicine for children:
No
Timeline
Today
3.5.2018Application
15.6.2018Publication
15.6.2020Registration
18.5.2031Expires
Marketing license
IS authorization number:
EU/1/15/1083/001-010Date:
26.5.2016
Foreign authorization number:
EU/1/15/1083Date:
12.5.2016
Owner
Name:
Nippon Shinyaku Co., Ltd.Address:
14, Kisshoin Nishinosho Monguchicho Minami-ku, Kyoto-shi Kyoto JP
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP2447254